Hi y'all
So this is worth a look. Leslie is in Vegas at a "Micro Cap" conference. Apparently what happens in Vegas doesn't stay in Vegas after all, because now we have a brief but interesting interview to watch. Points to note:
From 1:50 - 2:15 she gives a summary of Imugene's competitive advantage, stating that the B cell vaccine's have a huge advantage in terms of no toxicity but including this statement - "our cancer vaccines have proven a lot of efficacy as well as safety.."
Also 3:10 to 3:30. "So we have phenomenal response rates coming out of our phase 1b..."
Those who are unimpressed by Imugene will remain unimpressed.
Myself, I see encouraging results in the trials so far, huge confidence coming from the management team, recent additions to the Board which build enormous deal making capability and a share price which makes it a bargain buy for those willing to take a risk.
But hey - that's just me.
Cheers
Dave![]()
- Forums
- ASX - By Stock
- IMU
- Latest Interview with Leslie Chong
Latest Interview with Leslie Chong
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1368288 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 0.056 |
5 | 286362 | 0.055 |
12 | 3517552 | 0.054 |
17 | 2756044 | 0.053 |
23 | 2021898 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 1368288 | 7 |
0.058 | 2564048 | 15 |
0.059 | 3137099 | 10 |
0.060 | 2176188 | 16 |
0.061 | 1460386 | 7 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online